List of Studies ( Metabolite:TG 14:0_17:1_18:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004167 | AN006917 | Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells | Renal cancer cells | Human | Cancer | The Affiliated Cancer Hospital of Zhengzhou University | LC-MS |
| ST003760 | AN006174 | Untargeted lipidomics of combination gemcitabine/paclitaxel attenuated (CombAT) PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003757 | AN006168 | Untargeted lipidomics of gemcitabine-resistant PDAC cells | Pancreas | Human | Cancer | Victor Chang Cardiac Research Institute | LC-MS |
| ST003717 | AN006098 | Lipidomics analysis of mouse pancreatic cancer cells cultured RPMI, TIFM, or TIFM + arginine under lipid deprivation | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST003715 | AN006096 | Lipidomics analysis of mouse PDAC cell lines treated with tung oil | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST003714 | AN006095 | Lipidomics analysis of mouse PDAC cell lines treated with alpha-eleostearic acid | Cultured cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST003664 | AN006020 | Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. | T-cells | Mouse | Cancer | University of Chicago | LC-MS |
| ST002713 | AN004398 | Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics | Cultured cells | Human | Cancer | University of Colorado Denver | LC-MS |
| ST002414 | AN003935 | Mass spectrometry dataset of LC-MS Lipidomics Analysis of Xenopus Laevis Optic Nerve | Eye tissue | Frog | Eye disease | University of Miami | LC-MS |
| ST002243 | AN003661 | Lipidomics analysis of Friedreich's ataxia (FRDA) (part II) | Blood | Human | Friedreichs Ataxia | University of Pennsylvania | LC-MS |
